(Q28171078)
Statements
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study (English)
0 references
October 2004
0 references
25
0 references
20
0 references
1845-52
0 references